01 1Alembic Pharmaceuticals Limited
01 1FEBUXOSTAT
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-26
Pay. Date : 2013-02-06
DMF Number : 26417
Submission : 2012-10-01
Status : Active
Type : II
20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FEBUXOSTAT, with a corresponding US DMF Number 26417.
Remarkably, this DMF maintains an Active status since its submission on October 01, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 26, 2013, and payment made on February 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
